| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |